ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
Genelux Corporation

Genelux Corporation (GNLX)

3,73
0,33
(9,71%)
Fermé 18 Mars 9:00PM
3,715
-0,015
(-0,40%)
Après les heures de négociation: 12:59AM

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Statistiques et détails clés

Dernier
3,73
Prix Achat
3,80
Prix Vente
3,95
Volume échangé
112 460
3,40 Fourchette du Jour 3,78
1,60 Plage de 52 semaines 6,50
Cap du marché
Clôture Veille
3,40
Ouverture
3,4612
Dernière Transaction
1
@
3.91
Dernière heure de transaction
Volume financier
US$ 402 251
VWAP
3,5768
Volume moyen (3 m)
219 335
Actions en circulation
34 538 185
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-4,53
Bénéfice par action (BPA)
-0,82
Chiffre d'affairess
170k
Bénéfice net
-28,3M

À propos de Genelux Corporation

Genelux Corporation, a clinical-stage biopharmaceutical company, focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types. Its lead product candidate is Olvi-Vec, a proprietary, modified strain of the vac... Genelux Corporation, a clinical-stage biopharmaceutical company, focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types. Its lead product candidate is Olvi-Vec, a proprietary, modified strain of the vaccinia virus for the treatment of ovarian cancer and non-small-cell lung cancer. The company is also developing V2ACT Immunotherapy for the treatment of pancreatic cancer; and V-VET1, an animal health product candidate. It has a licensing agreement with ELIAS Animal Health, LLC. Genelux Corporation was incorporated in 2001 and is headquartered in Westlake Village, California. Show more

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Site Web
Siège social
Wilmington, Delaware, USA
Fondé
-
Genelux Corporation est coté dans le secteur Pharmaceutical Preparations de la NASDAQ avec le ticker GNLX. Le dernier cours de clôture d'Genelux était de US$3,40. Au cours de la dernière année, les actions de Genelux ont été négociées dans une fourchette de prix de US$ 1,60 à US$ 6,50.

Genelux compte actuellement 34 538 185 actions en circulation. La capitalisation boursière d'Genelux est de US$117,43 million. Genelux a un ratio cours/bénéfice (ratio PE) de -4.53.

GNLX Dernières nouvelles

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.55-12.85046728974.284.373.261180723.63609193CS
4-1.27-25.455.43.261640784.18954364CS
121.4362.17391304352.35.8852.162193353.95502873CS
261.17545.9882583172.5555.8851.951831563.354337CS
52-2.52-40.326.256.51.61978963.07324293CS
156-2.27-37.8333333333640.981.61623249.86614268CS
260-2.27-37.8333333333640.981.61623249.86614268CS

GNLX - Frequently Asked Questions (FAQ)

What is the current Genelux share price?
The current share price of Genelux is US$ 3,73
How many Genelux shares are in issue?
Genelux has 34 538 185 shares in issue
What is the market cap of Genelux?
The market capitalisation of Genelux is USD 117,43M
What is the 1 year trading range for Genelux share price?
Genelux has traded in the range of US$ 1,60 to US$ 6,50 during the past year
What is the PE ratio of Genelux?
The price to earnings ratio of Genelux is -4,53
What is the cash to sales ratio of Genelux?
The cash to sales ratio of Genelux is 757,14
What is the reporting currency for Genelux?
Genelux reports financial results in USD
What is the latest annual turnover for Genelux?
The latest annual turnover of Genelux is USD 170k
What is the latest annual profit for Genelux?
The latest annual profit of Genelux is USD -28,3M
What is the registered address of Genelux?
The registered address for Genelux is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Genelux website address?
The website address for Genelux is www.genelux.com
Which industry sector does Genelux operate in?
Genelux operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
ANTEAirNet Technology Inc
US$ 1,6001
(96,72%)
109,75M
SCNXScienture Holdings Inc
US$ 2,5589
(71,74%)
26,79M
VTVTvTv Therapeutics Inc
US$ 23,40
(57,58%)
514,8k
ARQQArqit Quantum Inc
US$ 23,615
(57,43%)
2,86M
MGRMMonogram Technologies Inc
US$ 3,65
(56,65%)
34,2M
BONBon Natural Life Ltd
US$ 0,5926
(-58,85%)
22,9M
LYTLytus Technologies Holdings PTV Ltd
US$ 0,0843
(-24,66%)
190,27M
STBXStarBox Group Holdings Ltd
US$ 0,2032
(-23,81%)
1,68M
COEPCoeptis Therapeutics Holdings Inc
US$ 8,50
(-23,15%)
214,76k
CTORCitius Oncology Inc
US$ 0,572
(-22,07%)
302,71k
NVDANVIDIA Corporation
US$ 119,53
(-1,76%)
253,72M
LYTLytus Technologies Holdings PTV Ltd
US$ 0,0843
(-24,66%)
190,27M
INTCIntel Corporation
US$ 25,69
(6,82%)
158,63M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 8,3401
(-9,54%)
154,01M
TSLATesla Inc
US$ 238,01
(-4,79%)
110,44M
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock